The Discounted Cash Flow (DCF) valuation of Regeneron Pharmaceuticals Inc (REGN) is 592.59 USD. With the latest stock price at 574.16 USD, the upside of Regeneron Pharmaceuticals Inc based on DCF is 3.2%.
Based on the latest price of 574.16 USD and our DCF valuation, Regeneron Pharmaceuticals Inc (REGN) is a buy. buying Regeneron stocks now will result in a potential gain of 3.2%.
| Range | Selected | |
| WACC / Discount Rate | 8.4% - 10.6% | 9.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 446.41 - 919.64 | 592.59 |
| Upside | -22.3% - 60.2% | 3.2% |